Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OsvaRen Granules vs Tablets Equivalence Study
NCT02027662Phase 3Completed
- Sponsor
- Fresenius Medical Care
- Start
- Jan 2014
- Primary completion
- Apr 2015
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of calcium acetate + magnesium carbonate in hyperphosphatemia, sponsored by Fresenius Medical Care. Started Jan 2014; status: completed.
02
Drugs
calcium acetate + magnesium carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT02027662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027662.